Interventional Cryoablation Therapy of Paroxysmal Atrial Fibrillation in Young Patients With Low CHADS2 Score: Worth the Risk of Periprocedural and Long-Term Adverse Events?
作者： Silke D. Braun
DOI: 10.1016/J.JACC.2013.04.096
关键词:
摘要: To alleviate palpitations and secondary detrimental effects in patients with atrial fibrillation (AF), the interventional AF therapies have become a kind of gold-standard treatment symptomatic AF, which is why about 50,000 procedures are performed each year United
onlinejacc.org 参考文章(3)
Douglas L Packer, Robert C Kowal, Kevin R Wheelan, James M Irwin, Jean Champagne, Peter G Guerra, Marc Dubuc, Vivek Reddy, Linda Nelson, Richard G Holcomb, John W Lehmann, Jeremy N Ruskin, STOP AF Cryoablation Investigators, None, Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. Journal of the American College of Cardiology. ,vol. 61, pp. 1713- 1723 ,(2013) , 10.1016/J.JACC.2012.11.064
K. Wasmer, L. Eckardt, Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines. Europace. ,vol. 13, pp. 1368- 1374 ,(2011) , 10.1093/EUROPACE/EUR172
Kumaraswamy Nanthakumar, James M. Mountz, Vance J. Plumb, Andrew E. Epstein, G. Neal Kay, Functional assessment of pulmonary vein stenosis using radionuclide ventilation/perfusion imaging. Chest. ,vol. 126, pp. 645- 651 ,(2004) , 10.1378/CHEST.126.2.645